These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17892493)

  • 21. Structural Analysis of the Pin1-CPEB1 interaction and its potential role in CPEB1 degradation.
    Schelhorn C; Martín-Malpartida P; Suñol D; Macias MJ
    Sci Rep; 2015 Oct; 5():14990. PubMed ID: 26456073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries.
    Wildemann D; Erdmann F; Alvarez BH; Stoller G; Zhou XZ; Fanghänel J; Schutkowski M; Lu KP; Fischer G
    J Med Chem; 2006 Apr; 49(7):2147-50. PubMed ID: 16570909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substrate Sequence Determines Catalytic Activities, Domain-Binding Preferences, and Allosteric Mechanisms in Pin1.
    Momin M; Yao XQ; Thor W; Hamelberg D
    J Phys Chem B; 2018 Jun; 122(25):6521-6527. PubMed ID: 29851476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis.
    Nakatsu Y; Sakoda H; Kushiyama A; Zhang J; Ono H; Fujishiro M; Kikuchi T; Fukushima T; Yoneda M; Ohno H; Horike N; Kanna M; Tsuchiya Y; Kamata H; Nishimura F; Isobe T; Ogihara T; Katagiri H; Oka Y; Takahashi S; Kurihara H; Uchida T; Asano T
    J Biol Chem; 2011 Jun; 286(23):20812-22. PubMed ID: 21454638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aluminum(III) interferes with the structure and the activity of the peptidyl-prolyl cis-trans isomerase (Pin1): a new mechanism contributing to the pathogenesis of Alzheimer's disease and cancers?
    Wang JZ; Liu J; Lin T; Han YG; Luo Y; Xi L; Du LF
    J Inorg Biochem; 2013 Sep; 126():111-7. PubMed ID: 23806774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxide-mediated oxidation and inhibition of the peptidyl-prolyl isomerase Pin1.
    Innes BT; Sowole MA; Gyenis L; Dubinsky M; Konermann L; Litchfield DW; Brandl CJ; Shilton BH
    Biochim Biophys Acta; 2015 May; 1852(5):905-12. PubMed ID: 25595659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of naturally occurring charged mutations on the structure, stability, and binding of the Pin1 WW domain.
    Qiao X; Liu Y; Luo L; Chen L; Zhao C; Ai X
    Biochem Biophys Res Commun; 2017 May; 487(2):470-476. PubMed ID: 28431929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate-based design of reversible Pin1 inhibitors.
    Zhang Y; Füssel S; Reimer U; Schutkowski M; Fischer G
    Biochemistry; 2002 Oct; 41(39):11868-77. PubMed ID: 12269831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual Roles of Pin1 in Cancer Development and Progression.
    Han HJ; Choi BY; Surh YJ
    Curr Pharm Des; 2017 Nov; 23(29):4422-4425. PubMed ID: 28671058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural and kinetic analysis of prolyl-isomerization/phosphorylation cross-talk in the CTD code.
    Zhang M; Wang XJ; Chen X; Bowman ME; Luo Y; Noel JP; Ellington AD; Etzkorn FA; Zhang Y
    ACS Chem Biol; 2012 Aug; 7(8):1462-70. PubMed ID: 22670809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the benefit of bivalency in peptide ligand/pin1 interactions.
    Daum S; Lücke C; Wildemann D; Schiene-Fischer C
    J Mol Biol; 2007 Nov; 374(1):147-61. PubMed ID: 17931657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease.
    Takahashi K; Uchida C; Shin RW; Shimazaki K; Uchida T
    Cell Mol Life Sci; 2008 Feb; 65(3):359-75. PubMed ID: 17965833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.
    Zheng H; You H; Zhou XZ; Murray SA; Uchida T; Wulf G; Gu L; Tang X; Lu KP; Xiao ZX
    Nature; 2002 Oct; 419(6909):849-53. PubMed ID: 12397361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational selection in the recognition of phosphorylated substrates by the catalytic domain of human Pin1.
    Velazquez HA; Hamelberg D
    Biochemistry; 2011 Nov; 50(44):9605-15. PubMed ID: 21967280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytosolic Aryl sulfotransferase 4A1 interacts with the peptidyl prolyl cis-trans isomerase Pin1.
    Mitchell DJ; Minchin RF
    Mol Pharmacol; 2009 Aug; 76(2):388-95. PubMed ID: 19439498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme-linked enzyme-binding assay for Pin1 WW domain ligands.
    Mercedes-Camacho AY; Etzkorn FA
    Anal Biochem; 2010 Jul; 402(1):77-82. PubMed ID: 20230769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Landscape of Pin1 in the cell cycle.
    Lin CH; Li HY; Lee YC; Calkins MJ; Lee KH; Yang CN; Lu PJ
    Exp Biol Med (Maywood); 2015 Mar; 240(3):403-8. PubMed ID: 25662955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focusing on the structure and the function of Pin1: new insights into the opposite effects of fever on cancers and Alzheimer's disease.
    Wang JZ; Zhang YH; Sun XW; Li YL; Li SR; Zhang Y; Zhang T; Song GQ
    Med Hypotheses; 2013 Aug; 81(2):282-4. PubMed ID: 23648381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function.
    Lu PJ; Zhou XZ; Liou YC; Noel JP; Lu KP
    J Biol Chem; 2002 Jan; 277(4):2381-4. PubMed ID: 11723108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The peptidyl-prolyl isomerase Pin1.
    Joseph JD; Yeh ES; Swenson KI; Means AR; Winkler
    Prog Cell Cycle Res; 2003; 5():477-87. PubMed ID: 14593743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.